Skip to main content

Want a detailed portfolio tracker?

Novartis (NVS) Total Debt (2006 - 2026)

Novartis (NVS) total debt from Mar 31, 2006 to Mar 31, 2026. The current Novartis (NVS) total debt is $80B. You can adjust inflation or export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Total Debt

Total Debt

Novartis (NVS) Total Debt CAGR table

PeriodCAGR
1 Year TTM+16.24%
3 Years TTM+4.46%
5 Years TTM-1.28%
10 Years TTM+1.85%
All Time TTM+4.83%

Annual Total Debt change of Novartis (NVS)

YearTotal DebtChange
2025$69B
+18.75%
2024$58B
+9.26%
2023$53B
-8.33%
2022$58B
-9.29%
2021$64B
-15.29%
2020$76B
+20.14%
2019$63B
-6.00%
2018$67B
+13.63%
2017$59B
+6.55%
2016$55B
+1.47%
2015$54B
-0.20%
2014$55B
+5.33%
2013$52B
-5.85%
2012$55B
+6.67%
2011$52B
-3.72%
2010$54B
+40.76%
2009$38B
+36.54%
2008$28B
+6.93%
2007$26B
-2.46%
2006$27B
N/A

Comparison Novartis (NVS) total debt with competitors

Novartis (NVS) total debt is $79.61B.

TickerNameTotal DebtUpside
MIRAMira Pharmaceuticals Inc$114761.00-100.00%
NSRXNasus Pharma Ltd$2.24M-100.00%
MDCXMDCorp$6.00M-99.99%
MDCXWMedicus Pharma Ltd warrant$6.00M-99.99%
AMRNAmarin Corp$196.35M-99.75%
SCLXScilex Holding Company$547.71M-99.31%
BIIBBiogen Inc$10.83B-86.39%
OGNOrganon & Company$12.09B-84.81%
GRFSGrifols SA$12.24B-84.62%
SNYSanofi$54.88B-31.06%
GSKGSK Plc$59.93B-24.71%
BMYBristol-Myers Squibb Company$66.37B-16.62%
AZNAstrazeneca plc$66.63B-16.30%
PFEPfizer Inc$117.21B+47.24%
JNJJohnson & Johnson$119.71B+50.38%